Publication Information

{'id': 'https://openalex.org/W2361701417', 'doi': None, 'title': 'Effect of Purendan Ultrafine Powder on the Expression of Vascular Endothelial Growth Factor in Retina of Diabetic Rats', 'display_name': 'Effect of Purendan Ultrafine Powder on the Expression of Vascular Endothelial Growth Factor in Retina of Diabetic Rats', 'publication_year': 2011, 'publication_date': '2011-01-01', 'ids': {'openalex': 'https://openalex.org/W2361701417', 'mag': '2361701417'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGYA201123006.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764872640', 'display_name': 'Zhongguo yaofang', 'issn_l': '1001-0408', 'issn': ['1001-0408'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4322615966', 'host_organization_name': 'China Pharmacy Publishing House', 'host_organization_lineage': ['https://openalex.org/P4322615966'], 'host_organization_lineage_names': ['China Pharmacy Publishing House'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5035935538', 'display_name': 'Tiemin Zhang', 'orcid': 'https://orcid.org/0000-0002-8003-984X'}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Zhang Tie-min', 'raw_affiliation_strings': ['Dept'], 'affiliations': [{'raw_affiliation_string': 'Dept', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5035935538'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 65}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T14144', 'display_name': 'Neurological Disease Mechanisms and Treatments', 'score': 0.9222, 'subfield': {'id': 'https://openalex.org/subfields/2808', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T14144', 'display_name': 'Neurological Disease Mechanisms and Treatments', 'score': 0.9222, 'subfield': {'id': 'https://openalex.org/subfields/2808', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12582', 'display_name': 'Flavonoids in Medical Research', 'score': 0.9108, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/intraperitoneal-injection', 'display_name': 'Intraperitoneal injection', 'score': 0.6874222}, {'id': 'https://openalex.org/keywords/rat-model', 'display_name': 'Rat model', 'score': 0.42852533}, {'id': 'https://openalex.org/keywords/normal-group', 'display_name': 'Normal group', 'score': 0.42383176}], 'concepts': [{'id': 'https://openalex.org/C2779829184', 'wikidata': 'https://www.wikidata.org/wiki/Q631361', 'display_name': 'Diabetic retinopathy', 'level': 3, 'score': 0.7596122}, {'id': 'https://openalex.org/C2779280383', 'wikidata': 'https://www.wikidata.org/wiki/Q257331', 'display_name': 'Streptozotocin', 'level': 3, 'score': 0.69756746}, {'id': 'https://openalex.org/C2780159080', 'wikidata': 'https://www.wikidata.org/wiki/Q1400536', 'display_name': 'Intraperitoneal injection', 'level': 2, 'score': 0.6874222}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.6114126}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.6069756}, {'id': 'https://openalex.org/C555293320', 'wikidata': 'https://www.wikidata.org/wiki/Q12206', 'display_name': 'Diabetes mellitus', 'level': 2, 'score': 0.5842774}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.58200276}, {'id': 'https://openalex.org/C2777025900', 'wikidata': 'https://www.wikidata.org/wiki/Q29725', 'display_name': 'Vascular endothelial growth factor', 'level': 3, 'score': 0.5791066}, {'id': 'https://openalex.org/C2777093970', 'wikidata': 'https://www.wikidata.org/wiki/Q169342', 'display_name': 'Retina', 'level': 2, 'score': 0.5453893}, {'id': 'https://openalex.org/C167734588', 'wikidata': 'https://www.wikidata.org/wiki/Q4356503', 'display_name': 'VEGF receptors', 'level': 2, 'score': 0.4384938}, {'id': 'https://openalex.org/C3019114686', 'wikidata': 'https://www.wikidata.org/wiki/Q3089676', 'display_name': 'Rat model', 'level': 2, 'score': 0.42852533}, {'id': 'https://openalex.org/C2992013202', 'wikidata': 'https://www.wikidata.org/wiki/Q743179', 'display_name': 'Normal group', 'level': 2, 'score': 0.42383176}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.12234759}, {'id': 'https://openalex.org/C169760540', 'wikidata': 'https://www.wikidata.org/wiki/Q207011', 'display_name': 'Neuroscience', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGYA201123006.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764872640', 'display_name': 'Zhongguo yaofang', 'issn_l': '1001-0408', 'issn': ['1001-0408'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4322615966', 'host_organization_name': 'China Pharmacy Publishing House', 'host_organization_lineage': ['https://openalex.org/P4322615966'], 'host_organization_lineage_names': ['China Pharmacy Publishing House'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.56, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3178126087', 'https://openalex.org/W3031535026', 'https://openalex.org/W3007054731', 'https://openalex.org/W2795450505', 'https://openalex.org/W2795310063', 'https://openalex.org/W2792872494', 'https://openalex.org/W2587952398', 'https://openalex.org/W2474913832', 'https://openalex.org/W2419419576', 'https://openalex.org/W2411252973', 'https://openalex.org/W2400876458', 'https://openalex.org/W2387160091', 'https://openalex.org/W2385683847', 'https://openalex.org/W2374693212', 'https://openalex.org/W2364463829', 'https://openalex.org/W2354239871', 'https://openalex.org/W2353374820', 'https://openalex.org/W2352562992', 'https://openalex.org/W2076657485', 'https://openalex.org/W2001907310'], 'abstract_inverted_index': {'OBJECTIVE:To': [0], 'study': [1, 58], 'the': [2, 9, 23, 59, 146, 152], 'effect': [3], 'of': [4, 11, 18, 26, 28, 37, 61, 64, 73, 110, 122, 148, 154, 159], 'Purendan': [5, 48, 87, 126], 'ultrafine': [6, 49, 88, 127, 135], 'powder': [7, 50, 89, 128, 136], 'on': [8], 'expression': [10, 25, 60, 147], 'vascular': [12], 'endothelial': [13], 'growth': [14], 'factor(VEGF)': [15], 'in': [16, 54, 67, 79, 86, 96, 113, 125, 157], 'retina': [17, 27, 158], 'diabetic': [19, 141, 160], 'rats': [20, 40, 68], 'by': [21, 34, 143], 'observing': [22], 'protein': [24], 'rats.METHODS:Diabetic': [29], 'rat': [30], 'models': [31], 'were': [32, 41, 52, 69, 77, 84, 94, 99], 'established': [33], 'intraperitoneal': [35], 'injection': [36], 'streptozotocin(STZ).The': [38], 'experimental': [39], 'divided': [42], 'into': [43], 'normal': [44, 80, 119], 'group,model': [45], 'group': [46, 115, 129], 'and': [47, 150], 'group,and': [51, 90], 'killed': [53], '5': [55, 105], 'months': [56, 106], 'to': [57], 'VGEF.The': [62], 'level': [63, 109, 121, 153], 'blood': [65, 111, 123, 155], 'glucose': [66, 112, 124, 156], 'determined': [70], 'after': [71], '1,3,5,months': [72], 'ig': [74, 107], 'administration.RESULTS:Negative': [75], 'results': [76, 83, 93], 'obtained': [78, 85, 95], 'group,weakly': [81], 'positive': [82, 92], 'strongly': [91], 'model': [97, 114, 133], 'group.There': [98], 'significant': [100], 'difference': [101], 'among': [102], 'those': [103], 'groups(P0.01).After': [104], 'administration,the': [108], 'increased': [116], 'significantly,compared': [117, 131], 'with': [118, 132], 'group.The': [120], 'decreased': [130], 'group(P0.01).CONCLUSION:Purendan': [134], 'may': [137], 'relieve': [138], 'or': [139], 'treat': [140], 'retinopathy': [142], 'actively': [144], 'suppressing': [145], 'VEGF': [149], 'decreasing': [151], 'rats.': [161]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2361701417', 'counts_by_year': [], 'updated_date': '2024-12-10T16:39:58.644093', 'created_date': '2016-06-24'}